Finance

Lists
Why is NTRA up २.५४%?
Dive Deeper
NTRA:NASDAQ
Natera Inc
US$ ४००.७१
+२.५४%
(+९.९२) 1D
US$ ४००.७१
०.००% (०.००)
After hours
Closed: अक्टोबर ९, १६:००:०० GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NTRA...
Open
US$ ३९२.९०
High
US$ ४०७.०६
Low
US$ ३९१.५१
Mkt. cap
५७.७६ अरब
Avg. vol.
१६.३७ लाख
Volume
१०.११ लाख
52-wk high
US$ ४३७.४१
52-wk low
US$ १६७.९८
EPS
-US$ १.३७
Beta
१.५०
Shares outstanding
१४.४१ करोड
No. of employees
६ हजार
Open
US$ ३९२.९०
High
US$ ४०७.०६
Low
US$ ३९१.५१
Mkt. cap
५७.७६ अरब
Avg. vol.
१६.३७ लाख
Volume
१०.११ लाख
52-wk high
US$ ४३७.४१
52-wk low
US$ १६७.९८
EPS
-US$ १.३७
Beta
१.५०
Shares outstanding
१४.४१ करोड
No. of employees
६ हजार
News stories
From web sources and news partners
AD HOC NEWS
AD HOC NEWS
·
१० घण्टा पहिले
Natera stock trades at EUR 357.80 in weekend trading
Investing.com Nigeria
Investing.com Nigeria
·
१४ घण्टा पहिले
Form 4 Natera Inc For: 9 October By Investing.com
AD HOC NEWS
AD HOC NEWS
·
१ दिन पहिले
Natera stock trades at EUR 359.55 with a minus 296.1 P/ E
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees६.१४ हजार
Founded२००४ जनवरी १
Headquartersअस्टिन, टेक्सस, संयुक्त राज्य अमेरिका
Sector-
Websitenatera.com
Analyst ratings
Based on 20 analysts giving stock ratings to NTRA in the past 3 months
Strong buy
Buy
19
Hold
1
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for NTRA in the last 3 months.
Highest
Current US$ ४००.७१
US$ ४८०.०० (+१९.७९%)
Average
US$ ३८३.२४ (-४.३६%)
Lowest
US$ ३२०.०० (-२०.१४%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luke Sergott
Barclays
Buy
Maintained
US$ ४७५.००
+१८.५%
10/07/2026
Patrick B Donnelly
Citi
Buy
Maintained
US$ ४८०.००
+१९.८%
10/06/2026
Albert Hu‏
Citi
Buy
Maintained
US$ ४८०.००
+१९.८%
10/06/2026
Subbu Nambi
Guggenheim
Buy
Maintained
US$ ४७५.००
+१८.५%
10/01/2026
Eve Burstein
Bernstein
Buy
Maintained
US$ ३६५.००
-८.९%
09/25/2026
Dan Leonard
RBC Capital
Buy
Maintained
US$ ४६०.००
+१४.८%
09/24/2026
Evie Koslosky
Goldman Sachs
Hold
Maintained
US$ ३७५.००
-६.४%
09/20/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Maintained
US$ ३५५.००
-११.४%
09/14/2026
Unknown Analyst
UBS
Buy
Maintained
US$ ४३५.००
+८.६%
09/09/2026
Doug Schenkel
UBS
Buy
Maintained
US$ ४३५.००
+८.६%
09/09/2026
Jamie Clark
Rothschild & Co Redburn
Buy
Initiated
US$ ३८५.००
-३.९%
09/08/2026
David Westenberg
Piper Sandler
Buy
Maintained
US$ ३६३.५०
-९.३%
08/24/2026
Tycho Peterson
Jefferies
Buy
Maintained
US$ ३३०.००
-१७.६%
08/17/2026
‏Brendan Digan‏
Citi
Buy
Maintained
US$ ३६५.००
-८.९%
08/14/2026
Unknown Analyst
Stephens
Buy
Maintained
US$ ३५०.००
-१२.७%
08/12/2026
Matt Larew
William Blair
Buy
Reiterated
-
-
08/07/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Maintained
US$ ३६०.००
-१०.२%
08/07/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
US$ ३४८.००
-१३.२%
08/07/2026
Kyle Mikson CFA
Canaccord Genuity
Buy
Maintained
US$ ३७५.००
-६.४%
08/07/2026
Brandon Couillard
Wells Fargo
Hold
Maintained
US$ २८४.००
-२९.१%
08/07/2026
Casey Woodring
J.P. Morgan
Buy
Reiterated
US$ ३६०.००
-१०.२%
08/07/2026
Mark Massaro
BTIG
Buy
Reiterated
US$ ३२०.००
-२०.१%
08/07/2026
Puneet Souda
Leerink Partners
Buy
Maintained
US$ ३३०.००
-१७.६%
08/07/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
US$ ३४०.००
-१५.२%
08/07/2026
William Bonello
Craig-Hallum
Buy
Maintained
-
-
07/09/2026
Paige Chamberlain‏
Wolfe Research
Buy
Reiterated
US$ २६०.००
-३५.१%
06/01/2026
Unknown Analyst
Wolfe Research
Buy
Reiterated
US$ २६०.००
-३५.१%
06/01/2026
Andrew Brackmann
William Blair
Buy
Maintained
-
-
05/08/2026
Unknown Analyst
Jefferies
Buy
Reiterated
US$ २७५.००
-३१.४%
02/27/2026
Last report
२०२६ अगस्ट ६
Fiscal period
Q2 2026
-US$ ०.४७ / -US$ ०.५३
+११.९९%beat
Revenue / Est. (USD)
७५.२८ करोड / ६६.१३ करोड
+१३.८३%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
५९.२२ करोड
६६.५५ करोड
६९.६६ करोड
७५.२८ करोड
Cost of goods sold
२०.७८ करोड
२२.०१ करोड
२४.५८ करोड
२६.७६ करोड
Cost of revenue
२०.७८ करोड
२२.०१ करोड
२४.५८ करोड
२६.७६ करोड
Research and development expenses
१७.३४ करोड
१७.५२ करोड
२१.०७ करोड
२२.८१ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३०.८५ करोड
२९.१३ करोड
३२.०७ करोड
३२.८९ करोड
Operating expense
४८.२० करोड
४६.८२ करोड
५३.७१ करोड
५६.२७ करोड
Total operating expenses
६८.९८ करोड
६८.८३ करोड
७८.३० करोड
८३.०२ करोड
Operating income
-९.७६ करोड
-२.२८ करोड
-८.६३ करोड
-७.७५ करोड
Other non operating income
-
-
-
-
EBT including unusual items
-८.७३ करोड
-१.३३ करोड
-८.४८ करोड
-६.७२ करोड
EBT excluding unusual items
-८.७३ करोड
-१.३३ करोड
-७.७६ करोड
-६.८९ करोड
Income tax expense
२.०७ लाख
-६.०६ करोड
२.८३ लाख
-२.६१ लाख
Effective tax rate
-०.२४%
४५४.६३%
-०.३३%
०.३९%
Other operating expenses
-
-
-
-
Net income
-८.७५ करोड
४.७३ करोड
-८.५१ करोड
-६.७० करोड
Net profit margin
-१४.७८%
७.१०%
-१२.२१%
-८.९०%
Earnings per share
-०.६४
०.३६
-०.६०
-०.४७
Interest and investment income
१.१३ करोड
१.०४ करोड
९६.०० लाख
९४.५२ लाख
Interest expense
-१०.४५ लाख
-९.९१ लाख
-८.९२ लाख
-८.९० लाख
Net interest expenses
१.०२ करोड
९४.५९ लाख
८७.०८ लाख
८५.६२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-८.७३ करोड
-१.३७ करोड
-६.६१ करोड
-५.६३ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू